Schmidt-Wolf G, Elsner F, Lindena G, Hilgers R-D, Heussen N, Rolke R, Ostgathe C, Radbruch L
Klinik für Palliativmedizin, Universitätsklinikum Bonn.
Dtsch Med Wochenschr. 2013 Dec;138(50):2585-91. doi: 10.1055/s-0033-1359858. Epub 2013 Dec 3.
With a priority programme the German Cancer Aid supported the development of quality-assured outpatient palliative care to cover the whole country. The 12 regional pilot projects funded with the aim to improve outpatient palliative care in different models and different frameworks were concurrently monitored and evaluated.
The supported projects, starting and ending individually, documented all patients who were cared for using HOPE (Hospice and palliative care evaluation) and MIDOS (Minimal documentation system for palliative patients). Total data were analyzed for 3239 patients decriptively. In addition to the quantitative data the experiences of the projects were recorded in a number of workshops (2008, 2009, 2010, and 2012). In particular, the experiences reported in the final meeting in July 2012 were considered for this article as well as the final reports for the German Cancer Aid.
In the quantitative evaluation 85.6% of 3239 palliative care patients had a cancer diagnosis. In all model projects the goal of a network with close cooperation of primary providers, social support, and outpatient and inpatient specialist services has been achieved. For all projects, the initial financing of the German Cancer Aid was extremely important, because contracts with health insurance funds were negotiated slowly, and could then be built on the experiences with the projects.
The participants of the project-completion meeting emphasized the need to carry out a market analysis before starting palliative care organizations considering the different regional structures and target groups of patients. Education, training and continuing education programs contribute significantly to the network. A reliably funded coordination center/case management across all institutions is extremely important.
德国癌症援助组织通过一个重点项目支持发展质量有保障的门诊姑息治疗,以覆盖全国。同时对12个旨在以不同模式和不同框架改善门诊姑息治疗的区域试点项目进行监测和评估。
所支持的项目各自独立启动和结束,使用HOPE(临终关怀与姑息治疗评估)和MIDOS(姑息患者最小文档系统)记录所有接受护理的患者。对3239例患者的总体数据进行描述性分析。除了定量数据外,还在多个研讨会(2008年、2009年、2010年和2012年)中记录了项目经验。本文特别考虑了2012年7月最后一次会议上报告的经验以及提交给德国癌症援助组织的最终报告。
在定量评估中,3239例姑息治疗患者中有85.6%被诊断患有癌症。在所有模式项目中,都实现了初级医疗服务提供者、社会支持以及门诊和住院专科服务密切合作的网络目标。对于所有项目而言,德国癌症援助组织的初始资金极为重要,因为与健康保险基金的合同谈判进展缓慢,之后可以基于项目经验来推进。
项目完成会议的参与者强调,在启动姑息治疗组织之前,需要考虑不同的区域结构和患者目标群体进行市场分析。教育、培训和继续教育项目对该网络有显著贡献。在所有机构中建立一个资金可靠的协调中心/病例管理机构极为重要。